Interaction of beta-amyloid interactions with peptide functionalized gold nanoparticles

Area of Science:

• Biomaterials Science
• Nanotechnology
• Neuroscience

Background:

• Beta-amyloid (1-42) aggregation is a hallmark of Alzheimer's disease.
• Gold nanoparticles (GNPs) offer a versatile platform for biomedical applications.
• Peptide functionalization can modulate nanoparticle interactions with biological targets.

Purpose of the Study:

• To investigate the interaction between peptide-functionalized gold nanoparticles and beta-amyloid (1-42).
• To evaluate the effect of different peptide sequences on GNP properties and protein binding.
• To assess the potential of these conjugates in preventing amyloid fibril formation and cytotoxicity.

Main Methods:

• Synthesis and characterization of 13 nm gold nanoparticles functionalized with CGGIGLMVG and CGGGGGIGLMVG peptides.
• Spectroscopic analysis (resonance absorption) of peptide-GNPs in the presence and absence of beta-amyloid (1-42).
• Assessment of beta-amyloid fibril formation and cytotoxicity inhibition.

Main Results:

• Peptide-functionalized GNPs were soluble and dispersed in aqueous buffer at pH 7.4.
• Significant changes in resonance absorption spectra (lambda(max) intensity) were observed upon interaction with beta-amyloid (1-42).
• The CGGGGGIGLMVG peptide-GNP conjugate showed the most pronounced spectral shift, suggesting stronger interaction.

Conclusions:

• Peptide-functionalized gold nanoparticles can interact with beta-amyloid (1-42).
• The sequence of the peptide linker significantly influences the interaction dynamics.
• The CGGGGGIGLMVG-GNP conjugate shows potential for therapeutic strategies targeting amyloid pathology.